These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

492 related items for PubMed ID: 18202762

  • 1. High expression of GADD-45alpha and VEGF induced tumor recurrence via upregulation of IL-2 after photodynamic therapy using NPe6.
    Ohtani K, Usuda J, Ichinose S, Ishizumi T, Hirata T, Inoue T, Maehara S, Imai K, Kubota M, Tsunoda Y, Yamada M, Tsutsui H, Yamada K, Kuroiwa Y, Furukawa K, Okunaka T, Kato H.
    Int J Oncol; 2008 Feb; 32(2):397-403. PubMed ID: 18202762
    [Abstract] [Full Text] [Related]

  • 2. Effect of hypericin-mediated photodynamic therapy on the expression of vascular endothelial growth factor in human nasopharyngeal carcinoma.
    Bhuvaneswari R, Gan YY, Yee KK, Soo KC, Olivo M.
    Int J Mol Med; 2007 Oct; 20(4):421-8. PubMed ID: 17786271
    [Abstract] [Full Text] [Related]

  • 3. Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma.
    Ferrario A, von Tiehl KF, Rucker N, Schwarz MA, Gill PS, Gomer CJ.
    Cancer Res; 2000 Aug 01; 60(15):4066-9. PubMed ID: 10945611
    [Abstract] [Full Text] [Related]

  • 4. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
    Peng Q, Warloe T, Moan J, Godal A, Apricena F, Giercksky KE, Nesland JM.
    Cancer Res; 2001 Aug 01; 61(15):5824-32. PubMed ID: 11479222
    [Abstract] [Full Text] [Related]

  • 5. Mechanistic investigation and implications of photodynamic therapy induction of vascular endothelial growth factor in prostate cancer.
    Solban N, Selbo PK, Sinha AK, Chang SK, Hasan T.
    Cancer Res; 2006 Jun 01; 66(11):5633-40. PubMed ID: 16740700
    [Abstract] [Full Text] [Related]

  • 6. Increased cytotoxic effects of photodynamic therapy in IL-6 gene transfected cells via enhanced apoptosis.
    Usuda J, Okunaka T, Furukawa K, Tsuchida T, Kuroiwa Y, Ohe Y, Saijo N, Nishio K, Konaka C, Kato H.
    Int J Cancer; 2001 Aug 15; 93(4):475-80. PubMed ID: 11477550
    [Abstract] [Full Text] [Related]

  • 7. Study of photodynamic efficiency of the hematoporphyrin conjugated with antibody to VEGF in mouse Lewis carcinoma.
    Novichenko NL, Mamchur AA, Lisniak IO, Gamaliya MF.
    Exp Oncol; 2008 Dec 15; 30(4):315-8. PubMed ID: 19112430
    [Abstract] [Full Text] [Related]

  • 8. Expression of vascular endothelial growth factor by photodynamic therapy with mono-L-aspartyl chlorin e6 (NPe6) in oral squamous cell carcinoma.
    Nakagawa H, Matsumiya T, Sakaki H, Imaizumi T, Kubota K, Kusumi A, Kobayashi W, Kimura H.
    Oral Oncol; 2007 Jul 15; 43(6):544-50. PubMed ID: 17257889
    [Abstract] [Full Text] [Related]

  • 9. A peptide competing with VEGF165 binding on neuropilin-1 mediates targeting of a chlorin-type photosensitizer and potentiates its photodynamic activity in human endothelial cells.
    Tirand L, Frochot C, Vanderesse R, Thomas N, Trinquet E, Pinel S, Viriot ML, Guillemin F, Barberi-Heyob M.
    J Control Release; 2006 Mar 10; 111(1-2):153-64. PubMed ID: 16423422
    [Abstract] [Full Text] [Related]

  • 10. CHOP activation by photodynamic therapy increases treatment induced photosensitization.
    Wong S, Luna M, Ferrario A, Gomer CJ.
    Lasers Surg Med; 2004 Mar 10; 35(5):336-41. PubMed ID: 15611953
    [Abstract] [Full Text] [Related]

  • 11. Celecoxib and NS-398 enhance photodynamic therapy by increasing in vitro apoptosis and decreasing in vivo inflammatory and angiogenic factors.
    Ferrario A, Fisher AM, Rucker N, Gomer CJ.
    Cancer Res; 2005 Oct 15; 65(20):9473-8. PubMed ID: 16230411
    [Abstract] [Full Text] [Related]

  • 12. Photodynamic therapy with mono-L-aspartyl chlorin e6 can cause necrosis of squamous cell carcinoma of tongue: experimental study on an animal model of nude mouse.
    Kobayashi W, Liu Q, Nakagawa H, Sakaki H, Teh B, Matsumiya T, Yoshida H, Imaizumi T, Satoh K, Kimura H.
    Oral Oncol; 2006 Jan 15; 42(1):46-50. PubMed ID: 16266818
    [Abstract] [Full Text] [Related]

  • 13. Molecular determinants of photodynamic therapy for lung cancers.
    Usuda J, Ichinose S, Ishizumi T, Ohtani K, Inoue T, Maehara S, Imai K, Shima K, Ohira T, Kato H, Ikeda N.
    Lasers Surg Med; 2011 Sep 15; 43(7):591-9. PubMed ID: 22057486
    [Abstract] [Full Text] [Related]

  • 14. Photodynamic therapy for lung cancers based on novel photodynamic diagnosis using talaporfin sodium (NPe6) and autofluorescence bronchoscopy.
    Usuda J, Tsutsui H, Honda H, Ichinose S, Ishizumi T, Hirata T, Inoue T, Ohtani K, Maehara S, Imai K, Tsunoda Y, Kubota M, Ikeda N, Furukawa K, Okunaka T, Kato H.
    Lung Cancer; 2007 Dec 15; 58(3):317-23. PubMed ID: 17698240
    [Abstract] [Full Text] [Related]

  • 15. Outcome of photodynamic therapy using NPe6 for bronchogenic carcinomas in central airways >1.0 cm in diameter.
    Usuda J, Ichinose S, Ishizumi T, Hayashi H, Ohtani K, Maehara S, Ono S, Honda H, Kajiwara N, Uchida O, Tsutsui H, Ohira T, Kato H, Ikeda N.
    Clin Cancer Res; 2010 Apr 01; 16(7):2198-204. PubMed ID: 20332318
    [Abstract] [Full Text] [Related]

  • 16. Tissue distribution and photosensitizing properties of mono-L-aspartyl chlorin e6 in a mouse tumor model.
    Gomer CJ, Ferrario A.
    Cancer Res; 1990 Jul 01; 50(13):3985-90. PubMed ID: 2354446
    [Abstract] [Full Text] [Related]

  • 17. Tailor-made approach to photodynamic therapy in the treatment of cancer based on Bcl-2 photodamage.
    Usuda J, Hirata T, Ichinose S, Ishizumi T, Inoue T, Ohtani K, Maehara S, Yamada M, Tsutsui H, Okunaka T, Kato H, Ikeda N.
    Int J Oncol; 2008 Oct 01; 33(4):689-96. PubMed ID: 18813781
    [Abstract] [Full Text] [Related]

  • 18. Detection of photodynamic therapy-induced early apoptosis in human salivary gland tumor cells in vitro and in a mouse tumor model.
    Kaneko T, Chiba H, Yasuda T, Kusama K.
    Oral Oncol; 2004 Sep 01; 40(8):787-92. PubMed ID: 15288832
    [Abstract] [Full Text] [Related]

  • 19. The effects of serum on cellular uptake and phototoxicity of mono-L-aspartyl chlorin e6 (NPe6) in vitro.
    Sheyhedin I, Aizawa K, Araake M, Kumasaka H, Okunaka T, Kato H.
    Photochem Photobiol; 1998 Jul 01; 68(1):110-4. PubMed ID: 9679456
    [Abstract] [Full Text] [Related]

  • 20. A possible relationship between the anti-cancer potency of photodynamic therapy using the novel photosensitizer ATX-s10-Na(II) and expression of the vascular endothelial growth factor in vivo.
    Okunaka T, Usuda J, Ichinose S, Hirata H, Ohtani K, Maehara S, Inoue T, Imai K, Kubota M, Tsunoda Y, Kuroiwa Y, Tsutsui H, Furukawa K, Nishio K, Kato H.
    Oncol Rep; 2007 Sep 01; 18(3):679-83. PubMed ID: 17671719
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.